Cita APA

Michels, S., & Provencio Pulla, M. (2024). Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer—final results of the EUCROSS trial.

Citación estilo Chicago

Michels, S., y Mariano Provencio Pulla. Overall Survival and Central Nervous System Activity of Crizotinib in ROS1-rearranged Lung Cancer—final Results of the EUCROSS Trial. 2024.

Cita MLA

Michels, S., y Mariano Provencio Pulla. Overall Survival and Central Nervous System Activity of Crizotinib in ROS1-rearranged Lung Cancer—final Results of the EUCROSS Trial. 2024.

Precaución: Estas citas no son 100% exactas.